Review Article

ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases

Table 6

Bioavailability of curcumin.

SpeciesRouteDosePlasma/tissueAUCRef

Rati.v.25 mg/kgLiverNA9.06 ± 1.55 min⋅g/mL [133]
HeartNA3.03 ± 0.85 min⋅g/mL
SpleenNA5.72 ± 1.14 min⋅g/mL
LungNA8.98 ± 1.82 min⋅g/mL
KidneyNA12.0 ± 0.88 min⋅g/mL
BrainNA4.04 ± 0.22 min⋅g/mL
RatOral50 mg/kgPlasma13.0 ± 5.8 ng/mL51.1 ± 25 min⋅g/mL [151]
300 mg/kgPlasma37.4 ± 36.1 ng/mL134 ± 114 min⋅g/mL
RatOral1 g/kgPlasma258.64 ng/mL2483.32 h⋅ng/mL [134]
HumanOral30 mg/kgPlasma1.8 ± 2.8 ng/mL4.1 ± 7 h⋅ng/mL [151]
HumanOral10 gPlasma50.5 ng/mLNA [132]
12 gPlasma57.6 ng/mLNA

i.v.: intravenous; i.g.: intragastric; , maximum concentration; AUC, area under the curve; NA, not applicable.